Current state of Alzheimer’s fluid biomarkers

Alzheimer’s disease (AD) is a progressive neurodegenerative disease with a complex and heterogeneous pathophysiology. The number of people living with AD is predicted to increase; however, there are no disease-modifying therapies currently available and none have been successful in late-stage clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Molinuevo, José Luis, Ayton, Scott, Batrla, Richard, Bednar, Martin M., Bittner, Tobias, Cummings, Jeffrey, Fagan, Anne M., Hampel, Harald, Mielke, Michelle M., Mikulskis, Alvydas, O’Bryant, Sid, Scheltens, Philip, Sevigny, Jeffrey, Shaw, Leslie M., Soares, Holly D., Tong, Gary, Trojanowski, John Q., Zetterberg, Henrik, Blennow, Kaj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280827/
https://www.ncbi.nlm.nih.gov/pubmed/30488277
http://dx.doi.org/10.1007/s00401-018-1932-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280827/
https://www.ncbi.nlm.nih.gov/pubmed/30488277
http://dx.doi.org/10.1007/s00401-018-1932-x

Ejemplares similares